Acute intermittent porphyria and epilepsy in a child: Dilemma in diagnosis and seizure management;Porphyrie aigue intermittente et epilepsie chez un meme enfant: Difficultes diagnostiques et therapeutiques

Archives de Pediatrie

Volumn 4, Issue 10, 1997, Pages 971-974

  Chaix, Y ^a   Gencourt, C ^a   Grouteau, E ^a   Carriere J P ^a  

^a CHU PURPAN   (France)

Author keywords

Anti convulsivants; Child; Clonazepam; Epilepsy; Porphyria; Porphyrins

Indexed keywords

CLONAZEPAM; ANTICONVULSIVE AGENT; VALPROIC ACID;

ACUTE INTERMITTENT PORPHYRIA; ANTICONVULSANT ACTIVITY; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CHILD; DISEASE ASSOCIATION; ENZYME ACTIVITY; EPILEPSY; HEME SYNTHESIS; HOSPITALIZATION; HUMAN; INBORN ERROR OF METABOLISM; MALE; DRUG COMBINATION; FOCAL EPILEPSY;

ANTICONVULSANTS; CHILD; CLONAZEPAM; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; HUMANS; MALE; PORPHYRIA, ACUTE INTERMITTENT; VALPROIC ACID;

EID: 0031243029     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)86093-9     Document Type: Article

References (13)

1. Kaplan PW, Lewis DV. Juvenile acute intermittent porphyriu with hypercholesterolemia and epilepsy: a case report and review of the literature. J Child Neurol 1986;1:38-43
2. Nordmann Y. Porphyries et porphyrinuries. Encycl Méd-Chir (Elsevier, Paris). Endocrinologie - Nutrition 1994; 10-360-E-10:1-14
3. Bylesjo I, Forsgren L, Lithner F, Boman K, Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epitepsia 1996;37:230-5
4. Yeung Laiwah AAC, Rapeport WC, Thompson GG et al. Carbamazepine-induced non-hereditary acute porphyria. Lancet 1983;i:790-2
5. Rideout JM, Wright DJ, Lim CK, Rinsler MG. Peters TJ. Carbamazepine-induced non-hereditary acute porphyria. Lancet 1983;ii:464
6. Doss M, Schafer HJ. Carbamazepine-induced acute porphyria syndrome Lancet 1984;i:1026
7. Nordmann Y, Deybach JC. Porphyries hépatiques: médicaments autorisés et interdits. Presse Méd 1987:16:327-30
8. Reynolds NC, Miska RM. Safety of anticonvulsivants in hepatic porphyrias. Neurology 1981;31:480-4
9. McGuire GM, Macphee GJA, Thompson GG, Moore MR, Brodie MJ. Effects of sodium valproate on haeme biosynthesis in man: implications for seizure management in the porphyric patient. Eur J Clin Invest 1988;18:29-32
10. Krauss GL, Simmons-O'Brien E, Campbell M. Successful treatment of seizures and porphyria with gabapentin. Neurology 1995;45:594-5
11. Tatum WO, Zachariah SB. Gabapentin treatment of seizures in acute intermittent porphyria. Neurology 1995;45: 1216-7
12. Bonkowsky HL. Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: Risks of valproate and clonazepam. Neurology 1980:30:588-92
13. Suzuki A, Aso K, Ariyoshi C, Ishimaru M. Acute intermittent porphyria and epilepsy: Safety of clonazepam. Epitepsia 1992;33:108-11